SCHEMBL19862984

SCHEMBL19862984

c1ccc(-c2cc(-n3c4ccccc4c4c5oc6ccccc6c5cc(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)c43)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.36
TSHR P16473 4/20 0.36
MAPK1 P28482 3/20 0.36
HSD17B10 Q99714 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 4/20 0.35
HPGD P15428 4/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 1/20 0.32
POLB P06746 2/20 0.32
ATM Q13315 1/20 0.31
MEN1 O00255 3/20 0.30
KMT2A Q03164 3/20 0.30
NTSR1 P30989 1/20 0.30
BRCA1 P38398 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863093 0.94 MAPT (0.39) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL19863058 0.94 MAPT (0.39) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL19862971 0.94 TSHR (0.35) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL19862991 0.94 TSHR (0.35) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL19862892 0.93 MAPT (0.36) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL19862978 0.92 KDM4E (0.36) MAPTTSHRMAPK1HSD17B10ALDH1A1
SCHEMBL19863067 0.90 MAPT (0.37) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL18594289 0.89 MAPT (0.40) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL18594348 0.89 MAPT (0.38) MAPTTSHRMAPK1HSD17B10NPSR1
SCHEMBL19862982 0.89 MAPT (0.34) MAPTTSHRMAPK1HSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885MAPK1 3622/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885MAPK1 3622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.